Zephyrus Biosciences Company

Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Addressing the burgeoning single-cell analysis market, our first product, the scWestern system, enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development.

Funding Status: M&A
Industry: Biotechnology, Hardware, Health Care
Technology: Regenerative Medicine
Number Of Exists: Seed
Headquarters: Berkeley, California, United States
Total Funding: $1.9M
Last Funding Type: Seed
Investor Type: For Profit
Employee Number: 1-10
Investors Number: 10
Founded Date: 2013-01-01